Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Theseus Pharmaceuticals Income Statement

Financials in millions JOD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	81.54	81.18	74.88	60.36	51.77	53.15
Revenue Growth (YoY)	5.13%	8.42%	24.06%	16.59%	-2.60%	-3.12%
Cost of Revenue	49.24	49.01	46.41	36.81	32.25	32.74
Gross Profit	32.3	32.17	28.47	23.55	19.52	20.41
Selling, General & Admin	22.64	23.31	20.15	17.66	15.69	15.73
Research & Development	1.18	1.06	1.27	1.13	1.04	0.85
Other Operating Expenses	-0.19	-0.16	-0.45	-0.43	-0.49	-0.52
Operating Expenses	24.04	24.65	21.39	18.99	16.14	16.64
Operating Income	8.26	7.51	7.08	4.56	3.38	3.78
Interest Expense	-4.03	-3.95	-3.83	-2.43	-2.71	-3.11
Interest & Investment Income	0.39	0.75	0.66	0.36	0.33	0.04
Earnings From Equity Investments	0.06	0.11	-0.14	-0.17	0.06	0.04
Currency Exchange Gain (Loss)	-0.31	-0.25	-0.37	-0.13	-0.14	-0.14
Other Non Operating Income (Expenses)	0.37	-	-	-	-	-
EBT Excluding Unusual Items	4.74	4.18	3.41	2.2	0.91	0.62
Merger & Restructuring Charges	-0.03	-0.07	-0.91	-	-	-
Gain (Loss) on Sale of Assets	-	-	0.09	-	-	8.34
Pretax Income	4.71	4.11	2.58	2.2	0.91	8.96
Income Tax Expense	0.46	0.39	-0.51	0.37	-0.01	0.42
Earnings From Continuing Operations	4.25	3.71	3.1	1.83	0.91	8.53
Net Income to Company	4.25	3.71	3.1	1.83	0.91	8.53
Minority Interest in Earnings	-0.12	-0.13	0.07	0.16	0.14	0.14
Net Income	4.14	3.59	3.16	1.99	1.05	8.68
Net Income to Common	4.14	3.59	3.16	1.99	1.05	8.68
Net Income Growth	33.57%	13.41%	59.21%	88.80%	-87.88%	-
Shares Outstanding (Basic)	35	35	35	35	34	25
Shares Outstanding (Diluted)	35	35	35	35	34	25
Shares Change (YoY)	0.91%	-	-	3.58%	35.16%	-
EPS (Basic)	0.12	0.10	0.09	0.06	0.03	0.35
EPS (Diluted)	0.12	0.10	0.09	0.06	0.03	0.35
EPS Growth	32.37%	13.41%	59.21%	82.27%	-91.03%	-
Free Cash Flow	-2.32	0.26	3.06	6.05	3.43	2.95
Free Cash Flow Per Share	-0.07	0.01	0.09	0.17	0.10	0.12
Dividend Per Share	-	-	-	0.050	-	-
Gross Margin	39.62%	39.63%	38.02%	39.02%	37.70%	38.41%
Operating Margin	10.13%	9.25%	9.45%	7.56%	6.52%	7.11%
Profit Margin	5.08%	4.42%	4.22%	3.29%	2.03%	16.33%
Free Cash Flow Margin	-2.84%	0.32%	4.08%	10.02%	6.64%	5.56%
EBITDA	12.3	11.37	10.59	8.03	6.83	7.26
EBITDA Margin	15.09%	14.01%	14.14%	13.31%	13.20%	13.66%
D&A For EBITDA	4.04	3.86	3.51	3.47	3.46	3.49
EBIT	8.26	7.51	7.08	4.56	3.38	3.78
EBIT Margin	10.13%	9.25%	9.45%	7.56%	6.52%	7.11%
Effective Tax Rate	9.69%	9.57%	-	16.76%	-	4.74%
Advertising Expenses	-	4.63	3.14	2.17	1.43	1.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.